Analysts Issue Forecasts for UnitedHealth Group Inc’s FY2019 Earnings (UNH)
UnitedHealth Group Inc (NYSE:UNH) – Equities research analysts at Cantor Fitzgerald issued their FY2019 EPS estimates for shares of UnitedHealth Group in a research note issued on Wednesday. Cantor Fitzgerald analyst S. Halper expects that the healthcare conglomerate will earn $13.80 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $280.00 target price on the stock.
Other research analysts also recently issued research reports about the company. Bank of America increased their price target on UnitedHealth Group from $230.00 to $240.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Citigroup increased their price target on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and set a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday, September 21st. Finally, Jefferies Group increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Friday, October 13th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $241.30.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.79% and a net margin of 5.25%. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.11 EPS.
Several large investors have recently added to or reduced their stakes in UNH. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $121,000. Finally, Acrospire Investment Management LLC increased its position in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the last quarter. 86.09% of the stock is currently owned by hedge funds and other institutional investors.
In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,655 shares of company stock worth $7,469,083. Insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.